|119.99||+1.98||+1.68%||Vol 390.04K||1Y Perf 10.57%|
|Apr 20th, 2021 16:00 DELAYED|
|- -||0.05 0.04%|
|Target Price||103.00||Analyst Rating||Hold 3.00|
|Potential %||-14.16||Finscreener Ranking||★★★★ 55.30|
|Insiders Trans % 3/6/12 mo.||-/-/-||Value Ranking||★★★★★ 62.96|
|Insiders Value % 3/6/12 mo.||-/-/-||Growth Ranking||★★★★★ 72.70|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-/-||Income Ranking||— -|
|Market Cap||4.72B||Earnings Rating||Buy|
|Price Range Ratio 52W %||99.70||Earnings Date||19th May 2021|
Today's Price Range
5 Year PE Ratio Range
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||19th May 2021|
|Estimated EPS Next Report||-|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||163.00K|
|Avg. Monthly Volume||109.33K|
|Avg. Quarterly Volume||161.07K|
China Biologic Products Holdings Inc. (NASDAQ: CBPO) stock closed at 119.99 per share at the end of the most recent trading day (a 1.68% change compared to the prior day closing price) with a volume of 390.92K shares and market capitalization of 4.72B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 2269 people. China Biologic Products Holdings Inc. CEO is Joseph Chow.
The one-year performance of China Biologic Products Holdings Inc. stock is 10.57%, while year-to-date (YTD) performance is 1.59%. CBPO stock has a five-year performance of -5.5%. Its 52-week range is between 99.74 and 120.05, which gives CBPO stock a 52-week price range ratio of 99.70%
China Biologic Products Holdings Inc. currently has a PE ratio of 30.70, a price-to-book (PB) ratio of 2.31, a price-to-sale (PS) ratio of 12.65, a price to cashflow ratio of 18.10, a PEG ratio of 2.32, a ROA of 6.97%, a ROC of 7.43% and a ROE of 7.95%. The company’s profit margin is 31.77%, its EBITDA margin is 43.90%, and its revenue ttm is $361.78 Million , which makes it $9.33 revenue per share.
Of the last four earnings reports from China Biologic Products Holdings Inc., there were 1 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. China Biologic Products Holdings Inc.’s next earnings report date is 19th May 2021.
The consensus rating of Wall Street analysts for China Biologic Products Holdings Inc. is Hold (3), with a target price of $103, which is -14.16% compared to the current price. The earnings rating for China Biologic Products Holdings Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
China Biologic Products Holdings Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
China Biologic Products Holdings Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 5.19, ATR14 : 1.30, CCI20 : 34.74, Chaikin Money Flow : 0.08, MACD : -0.19, Money Flow Index : 62.20, ROC : -0.34, RSI : 33.49, STOCH (14,3) : 48.85, STOCH RSI : 0.49, UO : 45.00, Williams %R : -51.15), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of China Biologic Products Holdings Inc. in the last 12-months were:
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.